Michel Dreano
Founder at Remedys Foundation
Profile
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Michel Dreano active positions
| Companies | Position | Start |
|---|---|---|
| Remedys Foundation | Founder | - |
Former positions of Michel Dreano
| Companies | Position | End |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Director of Finance/CFO | 2019-04-25 |
| Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | - |
Training of Michel Dreano
| L'Université de Bourgogne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Private companies | 4 |
|---|---|
| Université Paris Diderot-Paris 7 | Consumer Services |
| Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
| Remedys Foundation |
- Stock Market
- Insiders
- Michel Dreano
